J. Guarro et al., ACREMONIUM SPECIES - NEW EMERGING FUNGAL OPPORTUNISTS - IN-VITRO ANTIFUNGAL SUSCEPTIBILITIES AND REVIEW, Clinical infectious diseases, 25(5), 1997, pp. 1222-1229
We provide an overview of opportunistic fungal infections caused by Ac
remonium (Cephalosporium) species and discuss the classification of th
ese species as well as the diagnosis and treatment of acremonium infec
tions, We used a microdilution broth method to compare in vitro suscep
tibilities and minimum inhibitory concentrations and minimum fungicida
l concentrations of amphotericin B, miconazole, itraconazole, 5-fluoro
cytosine, fluconazole, and ketoconazole for 33 clinical and environmen
tal isolates of Acremonium. In general, the isolates tested displayed
little susceptibility to the antifungals tested. Fluconazole and 5-flu
orocytosine were ineffective in all cases. The efficacy of the remaini
ng drugs was dependent on the strain, Amphotericin B showed the best r
esults.